OOIR: Observatory of International Research

Papers

(The H4-Index of Harm Reduction Journal is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Acceptability of supervised injection facilities among persons who inject drugs in upstate New York	86
Decentralized HIV testing: comparing peer and mail-based distribution strategies to improve the reach of HIV self-testing among people who use drugs in Florida	78
Moving from ‘stigma reduction’ to ‘inclusion’: development of the inclusion collaborative at Nepean Blue Mountains Local Health District, New South Wales	59
The impact of institutionalization on the effectiveness of harm reduction: a qualitative study using drug users’ representations	55
Contamination of a drug consumption room with drugs and potential risks for social health care workers	51
A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City	47
Exploring perceived quality of life in long-term methadone-dependent patients: a qualitative study	45
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review	44
HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA	44
Drug checking services: barriers and facilitators to implementation by U.S. syringe services programs	42
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego–Tijuana border region	38
“The people who depended on us became expendable”: Experiences of frontline workers with lived and living expertise of drug use during the COVID-19 pandemic	36
Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior	35
Experiences of harm and mental ill-health among gay, bisexual and other men-who-have-sex-with-men who use methamphetamine or GHB/GBL in different combinations: findings from the COMeT study in Taiwan	34
Examining rural community pharmacists’ knowledge and practices in opioid overdose prevention and treatment services in the Southeastern United States	33
Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment	33
The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework	32
Drug decriminalization: a co-designed study outlining the implications for providers of youth services	32
Expanding single-venue services to better engage young people who inject drugs: insights from India	31
Welfare first: transforming harm reduction at UK festivals	31
Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study	31
Vaping among Norwegians who smoke or formerly smoked: reasons, patterns of use, and smoking cessation activity	30
Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals “blind spots” in detection capabilities	30
Online interventions and virtual day centres for young people who use drugs: potential for harm reduction?	30
“To not feel fake, it can’t be fake”: co-creation of a harm reduction, peer-delivered, health-system intervention for people who use drugs	29

“Expected to happen”: perspectives on post-release overdose from recently incarcerated people with opioid use disorder	29
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative	27
Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia’s drug supply	27
Accessing digital harm reduction services —exploring the impact of the “Here4UScotland” application	27